HSB 529 (LSB 5240HC (3) 83)

HOUSE FILE _____

BY  (PROPOSED COMMITTEE ON COMMERCE BILL BY CHAIRPERSON PETERSEN)

A BILL FOR

An Act relating to restrictions for drug product selection relative to antiepileptic drugs.
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:

    Section 1.  Section 155A.32, Code 2009, is amended by adding the following new subsection:
   NEW SUBSECTION.  2A.  The pharmacist shall not exercise the drug product selection described in this section for an antiepileptic drug or formulation of an antiepileptic drug, whether brand name or generic name, prescribed for the treatment of seizures including epilepsy, without prior notification of and receipt of the signed informed consent for that selection from both the authorized prescriber and the patient or the patient’s representative.
EXPLANATION
   This bill provides an exception to authorization of drug product selection by pharmacists by prohibiting such drug product selection for an antiepileptic drug or formulation of an antiepileptic drug, whether brand name or generic name, prescribed for the treatment of seizures including epilepsy, unless the pharmacist first provides notification of and receives signed informed consent for that selection from both the authorized prescriber and the patient or the patient’s representative.